Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

O. Kavanagh, Dara; Chambers, Gillian; O' Grady, Liam; M. Barry, Kevin; Waldron, R.; Bennani, Fadel; W. Eustace, Paul; Tobbia, I

doi:10.1186/1471-2407-9-1

Public

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

Published in BMC Cancer • Jan 1, 2009

Authors:

Dara O. Kavanagh

Gillian Chambers

Liam O' Grady

Abstract

BACKGROUND: The development of novel chemotherapeutic agents in colorectal cancer has improved survival. Following initial response to chemotherapeutic strategies many patients develop refractory disease. This poses a significant challenge common to many cancer subtypes. Newer agents such as Bevaciz...

Subject

Surgical oncology

Colorectal cancer

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!